As anti-Müllerian hormone belongs to transforming growth factor-β family and its representatives play an important role in ovarian cancer carcinogenesis, the aim of this study was to examine AMH concentration in ovarian cancer patients in relation to clinicopathological features, such as a pathological subtype of the tumor, FIGO stage, grading, and overall 5-year survival. This evidence concerns the gene AMH and ovarian carcinoma.